16-31473920-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000394863.8(TGFB1I1):āc.268C>Gā(p.Leu90Val) variant causes a missense change. The variant allele was found at a frequency of 0.000201 in 1,614,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00015 ( 0 hom., cov: 33)
Exomes š: 0.00021 ( 0 hom. )
Consequence
TGFB1I1
ENST00000394863.8 missense
ENST00000394863.8 missense
Scores
4
6
9
Clinical Significance
Conservation
PhyloP100: 6.43
Genes affected
TGFB1I1 (HGNC:11767): (transforming growth factor beta 1 induced transcript 1) This gene encodes a coactivator of the androgen receptor, a transcription factor which is activated by androgen and has a key role in male sexual differentiation. The encoded protein is thought to regulate androgen receptor activity and may have a role to play in the treatment of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.114490986).
BS2
High AC in GnomAd4 at 23 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFB1I1 | NM_001042454.3 | c.268C>G | p.Leu90Val | missense_variant | 4/11 | ENST00000394863.8 | NP_001035919.1 | |
TGFB1I1 | NM_001164719.1 | c.217C>G | p.Leu73Val | missense_variant | 4/11 | NP_001158191.1 | ||
TGFB1I1 | NM_015927.5 | c.217C>G | p.Leu73Val | missense_variant | 4/11 | NP_057011.2 | ||
TGFB1I1 | XM_024450412.2 | c.217C>G | p.Leu73Val | missense_variant | 4/11 | XP_024306180.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFB1I1 | ENST00000394863.8 | c.268C>G | p.Leu90Val | missense_variant | 4/11 | 1 | NM_001042454.3 | ENSP00000378332 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152106Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
23
AN:
152106
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000251 AC: 63AN: 251310Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135866
GnomAD3 exomes
AF:
AC:
63
AN:
251310
Hom.:
AF XY:
AC XY:
32
AN XY:
135866
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000206 AC: 301AN: 1461852Hom.: 0 Cov.: 32 AF XY: 0.000184 AC XY: 134AN XY: 727222
GnomAD4 exome
AF:
AC:
301
AN:
1461852
Hom.:
Cov.:
32
AF XY:
AC XY:
134
AN XY:
727222
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000151 AC: 23AN: 152224Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74424
GnomAD4 genome
AF:
AC:
23
AN:
152224
Hom.:
Cov.:
33
AF XY:
AC XY:
10
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
45
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.268C>G (p.L90V) alteration is located in exon 4 (coding exon 4) of the TGFB1I1 gene. This alteration results from a C to G substitution at nucleotide position 268, causing the leucine (L) at amino acid position 90 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.;.;.;.;.
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D;D;D;.;.
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;.;.;.;.;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;N;N;N;D;N;N
REVEL
Benign
Sift
Pathogenic
D;T;D;T;D;T;T
Sift4G
Uncertain
D;T;D;T;D;T;T
Polyphen
0.28
.;B;.;.;.;.;.
Vest4
0.32, 0.33, 0.33
MVP
MPC
0.12
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at